<DOC>
	<DOCNO>NCT01435486</DOCNO>
	<brief_summary>Viral bronchiolitis common low respiratory tract infection infancy . Apnea complication bronchiolitis , report 16 - 21 % case . Caffeine , trimethylxanthine , act antagonist endogenous adenosine potent central nervous system stimulant . In apnea prematurity , caffeine believe work increase central respiratory drive . Infants ≤4 month age , present pediatric emergency center Al-Sadd , September 2011 May 2014 , diagnosis viral bronchiolitis associate apnea . A randomized , double-blind , controlled trial sample size 45 patient per group Data Collection method , instrument use measurement : Randomization : In emergency department , patient assign either one two treatment use computer-generated randomized number 1:1 ratio . Pharmacy prepare sequential seal vial contain experimental drug . Randomization code reveal patient complete study . The medical team addition patient blind medication deliver . There detectable difference color , smell two study treatment . Guardians parent eligible infant approach regard study , explain purpose treatment modality . Patients include obtain verbal write consent . Study Intervention : Treatment 1 : Single stat dose ( 25 mg per kilogram body weight ) intravenous caffeine citrate ( 25mg caffeine citrate equal 12.5mg caffeine base ) . Treatment 2 : Placebo equivalent volume normal saline . Calculated study medication dilute Dextrose 5 % Water 20 ml give intravenous 30 minute use syringe infusion pump . After random assignment , eligible infant receive one study treatment . Non-pharmacological therapy may use necessary control apnea . Antibiotics antipyretic may use per discretion treat physician . After stabilization patient usually do Pediatric Emergency Center , patient admit pediatric intensive care unit ( PICU ) monitor monitoring indicate .</brief_summary>
	<brief_title>Caffeine Citrate Treatment Apnea Associated With Bronchiolitis Young Infants</brief_title>
	<detailed_description>Study area/setting : Pediatric emergency center Al-Sadd , ( PEC ) main pediatric emergency centre state Qatar approximately 200,000 visit annually . It capacity 42 observation bed provide inpatient facility except intensive care monitoring . Patients admit Pediatric Emergency Center manage discharge home unless Intensive Care Unit admission require . Study Subjects : - Inclusion criterion : Infants ≤4 month age , present pediatric emergency center Al-Sadd , September 2011 May 2014 , diagnosis viral bronchiolitis associate apnea . - Exclusion criterion : - Hypersensitivity caffeine . - Patients caffeine treatment . - Cardiovascular congenital abnormality . - Infants previous diagnosis gastroesophageal reflux disease . - Hypoglycemia and/or electrolytes disorder . - Suspected sepsis . - Seizure disorder . - Inborn error metabolism . - Renal and/or hepatic impairment . - Major congenital anomaly upper low respiratory tract ( severe tracheomalacia , trachea-esophageal fistula , diaphragmatic hernia , congenital lobar emphysema , congenital cystic adenomatoid malformation ) . Study Design : A randomized , double-blind , controlled trial . Sample Size : In retrospective chart review patient admitted institution PICU/step-down unit bronchiolitis associate apnea 2010 , 87 patient identify , 52 patient ( 60 % ) apnea free 12 hour admission . To enable detection 50 % improvement investigate group resolution apnea 12 hour 90 % power two side alpha= 0.05 , estimate 42 patient per group require . To compensate dropout , plan recruit 90 patient altogether . Data Collection method , instrument use measurement : Randomization : In emergency department , patient assign either one two treatment use computer-generated randomized number 1:1 ratio . Pharmacy prepare sequential seal vial contain experimental drug . Randomization code reveal patient complete study . The medical team addition patient blind medication deliver . There detectable difference color , smell two study treatment . Guardians parent eligible infant approach regard study , explain purpose treatment modality . Patients include obtain verbal write consent . Study Intervention : Treatment 1 : Single stat dose ( 25 mg per kilogram body weight ) intravenous caffeine citrate ( 25mg caffeine citrate equal 12.5mg caffeine base ) . Treatment 2 : Placebo equivalent volume normal saline . Calculated study medication dilute D5W 20 ml give intravenous 30 minute use syringe infusion pump . After random assignment , eligible infant receive one study treatment . Non-pharmacologic therapy supplemental oxygen , non invasive respiratory support , endotracheal intubation mechanical ventilation may use necessary control apnea . Antibiotics antipyretic may use per discretion treat physician . After stabilization patient usually do pediatric emergency center , patient admit Pediatric Intensive Care Unit monitoring indicate .</detailed_description>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Bronchiolitis</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<mesh_term>Caffeine</mesh_term>
	<mesh_term>Caffeine citrate</mesh_term>
	<criteria>Infants ≤4 month age , present pediatric emergency center AlSadd , September 2011 May 2014 , diagnosis viral bronchiolitis associate apnea . Hypersensitivity caffeine . Patients caffeine treatment . Cardiovascular congenital abnormality . Infants previous diagnosis gastroesophageal reflux disease . Hypoglycemia and/or electrolytes disorder . Suspected sepsis . Seizure disorder . Inborn error metabolism . Renal and/or hepatic impairment . Major congenital anomaly upper low respiratory tract ( severe tracheomalacia , tracheaesophageal fistula , diaphragmatic hernia , congenital lobar emphysema , congenital cystic adenomatoid malformation ) .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>4 Months</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>caffeine</keyword>
	<keyword>apnea</keyword>
	<keyword>bronchiolitis</keyword>
</DOC>